Neuroscientific Biopharmaceuticals Ltd. (AU:NSB) has released an update.
Neuroscientific Biopharmaceuticals Ltd. has fully adhered to the ASX Corporate Governance Council’s recommendations for the year ended June 2024, as detailed in their corporate governance statement available on their website. The company’s compliance includes the adoption of a board charter, execution of proper checks before appointments, and the presence of written agreements with directors and senior executives. Their commitment to transparency and governance is clearly communicated and accessible through a dedicated URL.
For further insights into AU:NSB stock, check out TipRanks’ Stock Analysis page.
